Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegaly.
Sebastian NeggersCorin BadiuBetina BiagettiLucie Durand-GasselinAnne PetitPatrick PetrossiansBenjamin RegnaultDavid RichZulfiya ShafigullinaSergey ShustovAnna VydrychPublished in: Expert review of clinical pharmacology (2021)
www.clinicaltrials.gov identifier is NCT02396953; EudraCT 2014-002389-62.
Keyphrases